Review Article | | Peer-Reviewed

Clinical Research and Artificial Intelligence: How AI Is Changing Clinical Research

Received: 5 April 2025     Accepted: 27 April 2025     Published: 26 June 2025
Views:       Downloads:
Abstract

Medicine is quickly transitioning as artificial intelligence (AI) adopts the new and improved type of machine learning for better diagnosis and treatment of diseases in the various sub-specialties of practice. The enhancement of computation rate raises the potential of AI algorithms and their value for multiple domains like radiology, where some experts suppose that AI can replace radiologists. These questions are essential when determining whether specific AI applications will eventually replace doctors or only assist them in their work within specific medical specialties. This paper ponders the iridescent role of AI in clinical trials and how its drug invention process will result from innovative learning in the future. The technology engages the role of AI in clinical decision support, the latest developments in precision medicine, and the prediction of drug properties and active ingredients. The paper showcases AI contributions to remodeling clinical trial designs and model exchange and using AI to carry out the intervention. Among other things, it speaks about AI in the acquisition of the EHR, in the course of authorization of the trial, and in addressing some of the significant challenges such as data availability and perpetual vigilance. In addition, a few discussions concerning clinical AI algorithm errors and the defects of conventional trial procedures are also incorporated at the end of the paper to portray the role of AI in present clinical research more sharply.

Published in American Journal of Artificial Intelligence (Volume 9, Issue 1)
DOI 10.11648/j.ajai.20250901.17
Page(s) 68-79
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

AI, Radiology, Technology, Clinical Trial, Clinical AI Algorithm

References
[1] Subrat Kumar Bhattamisra, et al. “Artificial Intelligence in Pharmaceutical and Healthcare Research.”. Big data and cognitive computing. 2023.
[2] Adam Bohr, Kaveh Memarzadeh. “The rise of artificial intelligence in healthcare applications”. Artificial Intelligence in Healthcare. 2020, Pages 25-60.
[3] Sudhakar P, SelvaPreethi S, and Anjali G. “Artificial Intelligence in Clinical Trials-Future Prospectives.” Bioequivalence and bioavailability international journal. 2023.
[4] Kanadpriya Basu. Ritwik Sinha. Aihui Ong. Treena Basu. “Artificial Intelligence : How is It Changing Medical Sciences and Its Future” ? Indian J Dermatol. 2020. pp-365–370.
[5] Bogoch L, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. “Pneumonia of unknown etiology in Wuhan, China : Potential for international spread via commercial air travel.” J Travel Med. 2020.
[6] Irfan Chaudhuri, Mark Tappan and Md. Shahidul Islam, Impact of Artificial Intelligence on Education: Present Realities and Future Considerations, J. Artif. Intel., 16 (1): 1-11, 2023,
[7] Irfan Chaudhuri and Md. Shahidul Islam, The Future of AI in Medicine: Present Realities and Future Considerations in Cardiology, Radiology and Ophthalmology, Int. J. Artificial Intelligence in Medicine (IJAIMED), 2(2), 7-26 2024,
[8] Matthew Hutson. “How AI is being used to accelerate clinical trials ?” NATURE INDEX. 2024.
[9] Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. “Precision Medicine, AI, and the future of Personalized Health Care”. Clin Transl Sci. 2021. pp-86–93.
[10] Quazi S. “Artificial intelligence and machine learning in precision and genomic medicine.” Med Oncol. 2022.
[11] Huang C, Clayton EA et al. “Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy.” Sci Rep. 2018.
[12] Sheu YH, Magdamo C, Miller M, Das S, Blacker D, Smoller JW. “AI-assisted prediction of differential response to antidepressant classes using electronic health records.” Digit Med. 2023.
[13] Luengo-Oroz, M., Pham, et. Al. “Artificial intelligence cooperation to support the global response to COVID-19”. Nature Machine Intelligence. 2020. pp: 295–297.
[14] Lip, S., Visweswaran, S., & Padmanabhan, S. “Transforming Clinical Trials with Artificial Intelligence.” In Artificial Intelligence. Productivity Press. 2020. pp: 297–306.
[15] Sucharitha, G., & Chary, D. V. “Predicting the effect of Covid-19 by using artificial intelligence: A case study. Materials Today: Proceedings”. Research gate. 2021.
[16] Shaheen, M. Y. “Adoption of machine learning for medical diagnosis.” ScienceOpen. 2021.
[17] Harrer, S., Shah, P., Antony, B., & Hu, J. “Artificial intelligence for clinical trial design.” Trends in Pharmacological Sciences. 2019 . pp: 577–591.
[18] Delso G, Cirillo D, Kaggie JD, Valencia A, Metser U, VeitHaibach P. “How to design AI-Driven clinical trials in Nuclear Medicine”. Semin Nucl Med. 2021.112–9.
[19] Group S-I, Cerf, French Radiology C. “Artificial intelligence and medical imaging 2018: French radiology community white paper”. Diagn Interv Imaging. 2018. Pp: 727–742.
[20] CS L, AY L. “How Artificial Intelligence Can Transform Randomized Controlled Trials.” Translational vision science & technology. 2020.
[21] Angus, D. C. (2020). Randomized clinical trials of artificial intelligence. Jama. 2020. pp-1043-1045.
[22] Lee, E. “How do we build trust in machine learning models?” SSRN. 2021.
[23] Mohammed Yousef Shaheen. “Applications of Artificial Intelligence (AI) in healthcare: A review”. Scienceopen.com. 2021.
[24] Duckworth, C. et al. “Using explainable machine learning to characterize data drift and detect emergent health risks for emergency department admissions during COVID-19”. Sci. Rep. 11. 2021.
[25] Sheela Kolluri et al. “Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review.” National library of medicine. 2022.
[26] Waymel Q, Badr S, Demondion X, Cotten A, Jacques T. “Impact of the rise of artificial intelligence in radiology: what do radiologists think?” Diagn Interv Imaging. 2019. Pp: 327–336.
[27] Farah Magrabi et al. “Artificial Intelligence in Clinical Decision Support: Challenges for Evaluating AI and Practical Implications”. Pubmed Central. 2019.
[28] Braz. J. “ Revolutionizing Medicine: Unleashing the Power of Real-World Data and AI in Advancing Clinical Trials.” Pharm. Sci. 2024.
[29] Briel M, Elger BS, McLennan S, Schandelmaier S, von Elm E, Satalkar P. “Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada.” Trials. 2021.
[30] Zeng J, Banerjee I, Henry AS, et al. “Natural language processing to identify cancer treatments with electronic medical records. JCO Clin Cancer Info”. 2021. Pp: 379–93.
[31] Ezzati, A. et al. “Machine learning predictive models can improve the efficacy of clinical trials for Alzheimer’s disease.” J. Alzheimers Dis. 2020. Pp-55–63.
[32] Mohan, A. et al. “A machine-learning derived Huntington’s disease progression model: insights for clinical trial design.” Mon. Disord. 2022. Pp-553–562.
[33] de Jong, J. et al. “Towards realizing the vision of precision medicine: AI-based prediction of clinical drug response.” Brain 144. 22021. Pp-1738–1750.
[34] Kann BH, Hosny A, Aerts HJWL. “Artificial intelligence for clinical oncology”. Cancer Cell. 39, 2021. Pp: 916–927
[35] Wang S, Chen A, Yang L, et al. “Comprehensive analysis of lung cancer pathology images to discover tumor shape and boundary features that predict survival outcome.” Sci Rep. 2018.
[36] Karimi YH, Blayney DW, Kurian AW, et al. “Development and use of natural language processing for identification of distant cancer recurrence and sites of distant recurrence using unstructured electronic health record data.” JCO Clin Cancer Info. 2021. Pp: 469–78.
[37] Voermans AM, Mewes JC, Broyles MR, Steuten LMG. “Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data.” OMICS. 2019. Pp-508-515.
[38] Santín, E. P. Solana, R. R. García, et. al. “Toxicity prediction based on artificial intelligence: A multidisciplinary overview.” Wiley Interdiscip. Rev. Comput. Mol. Sci. 2021.
[39] Jang, H. Y. Song, J. Kim, J. H. Lee, H. Kim, I. W. Moon, B. Oh, J. M. “Machine learning-based quantitative prediction of drug exposure in drug-drug interactions using drug label information.” npj Digit. Med. 2022.
Cite This Article
  • APA Style

    Majid, Z., Islam, M. S. (2025). Clinical Research and Artificial Intelligence: How AI Is Changing Clinical Research. American Journal of Artificial Intelligence, 9(1), 68-79. https://doi.org/10.11648/j.ajai.20250901.17

    Copy | Download

    ACS Style

    Majid, Z.; Islam, M. S. Clinical Research and Artificial Intelligence: How AI Is Changing Clinical Research. Am. J. Artif. Intell. 2025, 9(1), 68-79. doi: 10.11648/j.ajai.20250901.17

    Copy | Download

    AMA Style

    Majid Z, Islam MS. Clinical Research and Artificial Intelligence: How AI Is Changing Clinical Research. Am J Artif Intell. 2025;9(1):68-79. doi: 10.11648/j.ajai.20250901.17

    Copy | Download

  • @article{10.11648/j.ajai.20250901.17,
      author = {Zomana Majid and Md Shahidul Islam},
      title = {Clinical Research and Artificial Intelligence: How AI Is Changing Clinical Research},
      journal = {American Journal of Artificial Intelligence},
      volume = {9},
      number = {1},
      pages = {68-79},
      doi = {10.11648/j.ajai.20250901.17},
      url = {https://doi.org/10.11648/j.ajai.20250901.17},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajai.20250901.17},
      abstract = {Medicine is quickly transitioning as artificial intelligence (AI) adopts the new and improved type of machine learning for better diagnosis and treatment of diseases in the various sub-specialties of practice. The enhancement of computation rate raises the potential of AI algorithms and their value for multiple domains like radiology, where some experts suppose that AI can replace radiologists. These questions are essential when determining whether specific AI applications will eventually replace doctors or only assist them in their work within specific medical specialties. This paper ponders the iridescent role of AI in clinical trials and how its drug invention process will result from innovative learning in the future. The technology engages the role of AI in clinical decision support, the latest developments in precision medicine, and the prediction of drug properties and active ingredients. The paper showcases AI contributions to remodeling clinical trial designs and model exchange and using AI to carry out the intervention. Among other things, it speaks about AI in the acquisition of the EHR, in the course of authorization of the trial, and in addressing some of the significant challenges such as data availability and perpetual vigilance. In addition, a few discussions concerning clinical AI algorithm errors and the defects of conventional trial procedures are also incorporated at the end of the paper to portray the role of AI in present clinical research more sharply.},
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Clinical Research and Artificial Intelligence: How AI Is Changing Clinical Research
    AU  - Zomana Majid
    AU  - Md Shahidul Islam
    Y1  - 2025/06/26
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ajai.20250901.17
    DO  - 10.11648/j.ajai.20250901.17
    T2  - American Journal of Artificial Intelligence
    JF  - American Journal of Artificial Intelligence
    JO  - American Journal of Artificial Intelligence
    SP  - 68
    EP  - 79
    PB  - Science Publishing Group
    SN  - 2639-9733
    UR  - https://doi.org/10.11648/j.ajai.20250901.17
    AB  - Medicine is quickly transitioning as artificial intelligence (AI) adopts the new and improved type of machine learning for better diagnosis and treatment of diseases in the various sub-specialties of practice. The enhancement of computation rate raises the potential of AI algorithms and their value for multiple domains like radiology, where some experts suppose that AI can replace radiologists. These questions are essential when determining whether specific AI applications will eventually replace doctors or only assist them in their work within specific medical specialties. This paper ponders the iridescent role of AI in clinical trials and how its drug invention process will result from innovative learning in the future. The technology engages the role of AI in clinical decision support, the latest developments in precision medicine, and the prediction of drug properties and active ingredients. The paper showcases AI contributions to remodeling clinical trial designs and model exchange and using AI to carry out the intervention. Among other things, it speaks about AI in the acquisition of the EHR, in the course of authorization of the trial, and in addressing some of the significant challenges such as data availability and perpetual vigilance. In addition, a few discussions concerning clinical AI algorithm errors and the defects of conventional trial procedures are also incorporated at the end of the paper to portray the role of AI in present clinical research more sharply.
    VL  - 9
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Sections